CN Patent

CN114302716B — 抑制阿塞那平-n-氧化物的生成的方法

Assigned to Hisamitsu Pharmaceutical Co Inc · Expires 2024-09-17 · 2y expired

What this patent protects

本发明提供一种贴剂，其是在支持体上具备粘合剂层的贴剂，其中，所述粘合剂层含有：阿塞那平或其药学上可接受的盐、粘合基剂、以及选自硫代硫酸盐、亚硫酸盐和焦亚硫酸盐中的至少1种。

USPTO Abstract

本发明提供一种贴剂，其是在支持体上具备粘合剂层的贴剂，其中，所述粘合剂层含有：阿塞那平或其药学上可接受的盐、粘合基剂、以及选自硫代硫酸盐、亚硫酸盐和焦亚硫酸盐中的至少1种。

Drugs covered by this patent

Patent Metadata

Patent number
CN114302716B
Jurisdiction
CN
Classification
—
Expires
2024-09-17
Drug substance claim
No
Drug product claim
No
Assignee
Hisamitsu Pharmaceutical Co Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.